中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of sars-like coronavirus generates humoral and cellular immune responses

文献类型:期刊论文

作者Bai, Bingke1,2; Lu, Xinya1,2; Meng, Jin1,2; Hu, Qinxue1; Mao, Panyong3; Lu, Baojing1,2; Chen, Ze1; Yuan, Zhiming1; Wang, Hanzhong1
刊名Molecular immunology
出版日期2008-02-01
卷号45期号:4页码:868-875
关键词Cellular immune response Humoral immune response Recombinant baculovirus Sars-like coronavirus
ISSN号0161-5890
DOI10.1016/j.molimm.2007.08.010
通讯作者Wang, hanzhong(wanghz@wh.iov.cn)
英文摘要Continuous efforts have been made to develop a prophylactic vaccine against severe acute respiratory syndrome coronavirus (sars-cov). in this study, two recombinant baculoviruses, vac-n and vac-s, were constructed, which contained the mammalian-cell activate promoter element, human elongation factor la-subunit (ef-1 alpha), the human cytomegalovirus (cmv) immediate-early promoter, and the nucleocapsid (n) or spike (s) gene of bat sars-like cov (sl-cov) under the control of the cmv promoter. mice were subcutaneously and intraperitoneally injected with recombinant baculovirus, and both humoral and cellular immune responses were induced in the vaccinated groups. the secretion level of ifn-gamma was much higher than that of il-4 in vac-n or vac-s immunized groups, suggesting a strong th 1 bias towards cellular immune responses. additionally, a marked increase of cd4 t cell immune responses and high levels of anti-sars-cov immoral responses were also detected in the vac-n or vac-s immunized groups. in contrast, there were significantly weaker cellular immune responses, as well as less antibody production than in the control groups. our data demonstrates that the recombinant baculovirus can serve as an effective vaccine strategy. in addition, because effective sars vaccines should act to not only prevent the reemergence of sars-cov, but also to provide cross-protection against sl-cov, findings in this study may have implications for developing such cross-protective vaccines. (c) 2007 elsevier ltd. all rights reserved.
WOS关键词ACUTE-RESPIRATORY-SYNDROME ; EFFICIENT GENE-TRANSFER ; MAMMALIAN-CELLS ; INSECT CELLS ; DNA VACCINE ; INFECTIOUS-BRONCHITIS ; STRUCTURAL PROTEINS ; PROTECTIVE IMMUNITY ; MEDIATED EXPRESSION ; ANTIBODY-RESPONSES
WOS研究方向Biochemistry & Molecular Biology ; Immunology
WOS类目Biochemistry & Molecular Biology ; Immunology
语种英语
WOS记录号WOS:000252232400002
出版者PERGAMON-ELSEVIER SCIENCE LTD
URI标识http://www.irgrid.ac.cn/handle/1471x/2375511
专题武汉病毒研究所
通讯作者Wang, Hanzhong
作者单位1.Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China
2.Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China
3.302 Hosp, Inst Infect Dis, Dept Virol, Beijing 100039, Peoples R China
推荐引用方式
GB/T 7714
Bai, Bingke,Lu, Xinya,Meng, Jin,et al. Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of sars-like coronavirus generates humoral and cellular immune responses[J]. Molecular immunology,2008,45(4):868-875.
APA Bai, Bingke.,Lu, Xinya.,Meng, Jin.,Hu, Qinxue.,Mao, Panyong.,...&Wang, Hanzhong.(2008).Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of sars-like coronavirus generates humoral and cellular immune responses.Molecular immunology,45(4),868-875.
MLA Bai, Bingke,et al."Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of sars-like coronavirus generates humoral and cellular immune responses".Molecular immunology 45.4(2008):868-875.

入库方式: iSwitch采集

来源:武汉病毒研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。